CEO: Sergio Traversa
Employees: 17
IPO: Jun 20, 2014
Prix
6,96 €
Variation
▲ 0,58 €
9,09%
Cap. Boursière
510,40M
Fourchette du Jour
6,38 €
6,96 €
Fourchette 52 Semaines
0,24 €
7,51 €
Volume
2 185 032
Moyenne 50J / 200J
4,80 €
2,83 €
Clôture Précédente
6,38 €
Quick Summary
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -45,79M
PEG of 0,07 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-94,05%
En dessous de la moyenne du secteur (3,68%)
ROIC-51,24%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
En dessous de la moyenne du secteur (0,24)
Current Ratio14,62
Interest Coverage0,00
Valorisation
P/E Ratio
-8,89
En dessous de la moyenne du secteur (0,23)
Forward P/EN/A
P/B Ratio5,90
EV/EBITDAN/A
Dividend Yield0,00%
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (635 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -8,9 | 0,2 |
| P/B | 5,9 | 2,9 |
| ROE % | -94,1 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 9,6 |
| D/E | 0,0 | 0,2 |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -57,39M |
| ROE | -94,05% | ROA | -61,05% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -45,79M |
| ROIC | -51,24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 14,62 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8,89 | Forward P/E | N/A |
| P/B Ratio | 5,90 | P/S Ratio | N/A |
| PEG Ratio | 0,07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8,97% | ||
| Market Cap | 510,40M | Enterprise Value | 506,91M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -57,39M | -79,98M | -98,79M | -157,04M | -125,75M |
| EPS (Diluted) | -1,45 | -2,65 | -3,28 | -5,30 | -7,16 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -59,10M | -83,89M | -103,70M | -161,25M | -125,70M |
| EBITDA | -59,10M | -83,89M | 4,91M | -161,25M | -125,70M |
| R&D Expenses | 744 560,0 | 46,18M | 54,81M | 113,32M | 90,62M |
| SG&A Expenses | 311 904,0 | 37,72M | 48,90M | 47,93M | 35,08M |
| D&A | 0,0 | 0,0 | 103,70M | 2 000,0 | 1 258,0 |
| Interest Expense | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 94,00M | 45,82M | 97,55M | 152,91M | 223,33M |
| Total Liabilities | 7,49M | 10,30M | 12,19M | 12,47M | 15,06M |
| Shareholders' Equity | 86,51M | 35,52M | 85,36M | 140,44M | 208,26M |
| Total Debt | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Cash & Equivalents | 3,50M | 3,86M | 4,09M | 5,40M | 44,44M |
| Current Assets | 93,98M | 45,80M | 97,51M | 152,87M | 223,30M |
| Current Liabilities | 6,43M | 10,29M | 12,19M | 12,47M | 15,06M |